SCHEMBL3176064

SCHEMBL3176064

COCCN1CCN(CC(=O)Nc2cc(NCCNC(C)=O)nc(-c3ccccc3)n2)CC1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ WNT3A P56704 5/20 0.45
▸ ADORA3 P0DMS8 5/20 0.44
▸ ADORA2A P29274 5/20 0.43
▸ ADORA1 P30542 5/20 0.43
▸ ADORA2B P29275 4/20 0.43
▸ KCNA5 P22460 4/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ CLK4 Q9HAZ1 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3171439 0.91 ADORA3 (0.43) WNT3AADORA3ADORA2AADORA1ADORA2B
SCHEMBL3169937 0.90 ALDH1A1 (0.48) ADORA3ADORA2AADORA1ADORA2BALDH1A1
SCHEMBL3165191 0.88 ADORA2A (0.51) ADORA3ADORA2AADORA1ADORA2BALDH1A1
SCHEMBL3161606 0.88 ADORA1 (0.47) ADORA3ADORA2AADORA1ADORA2BALDH1A1
SCHEMBL3171920 0.88 ADORA1 (0.47) ADORA3ADORA2AADORA1ADORA2BKDM4E
SCHEMBL3155733 0.88 ADORA2B (0.48) ADORA3ADORA2AADORA1ADORA2BCYP1A2
SCHEMBL3163144 0.87 ADORA3 (0.46) ADORA3ADORA2AADORA1ADORA2BTSHR
SCHEMBL3164709 0.87 NPC1 (0.47) ADORA3ADORA2AADORA1ADORA2BKDM4E
SCHEMBL3163125 0.87 NPC1 (0.47) ADORA3ADORA2AADORA1ADORA2BKDM4E
SCHEMBL3162838 0.87 ADORA3 (0.58) ADORA3ADORA2AADORA1ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback